eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Pierre Fabre Limited
Hyde Abbey House, 23 Hyde Street, Winchester, Hampshire, SO23 7DR
Telephone: +44 (0)1962 874 400
Fax: +44 (0)1962 844 014
Medical Information Direct Line: +44 (0)1962 874 435
Medical Information e-mail: medicalinformation@pierre-fabre.co.uk
Customer Care direct line: +44 (0)1962 874 402
Medical Information Fax: +44 (0)1962 874 413

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 04/08/2011
PIL Busilvex 6 mg/ml concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 04/08/2011 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 02/08/2011 and displayed until 04/08/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 20/08/2008 and displayed until 02/08/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to storage instructions
  • Change to information about pregnancy or lactation
Updated on 18/01/2008 and displayed until 20/08/2008
Reasons for adding or updating:
  • Change to storage instructions
  • Change to how the medicine works
  • Change to Further Information section
  • Change to dosage and administration
Updated on 14/02/2006 and displayed until 18/01/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to how the medicine works
  • Change to Further Information section
  • Change to date of revision
  • Change to dosage and administration
Updated on 23/05/2005 and displayed until 14/02/2006
Reasons for adding or updating:
  • Change of manufacturer
Updated on 02/09/2004 and displayed until 23/05/2005
Reasons for adding or updating:
  • Change to date of revision
Updated on 27/08/2004 and displayed until 02/09/2004
Reasons for adding or updating:
  • New PIL for new product
  • Pending awaiting re-submission

Active Ingredients/Generics

 
  busulfan